A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 6, 2000, Pages 513-524

  Ishizawa, Keisuke ^a   Lin, Wen Lang ^a   Tiseo, Paul ^a   Honer, William G ^b   Davies, Peter ^c   Dickson, Dennis W ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Dentate nucleus; Grumose degeneration; Microglia; Oligodendroglia; Progressive supranuclear palsy; Tau

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENTATE NUCLEUS; FEMALE; GLIOSIS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; WHITE MATTER;

EID: 0034123457     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.6.513     Document Type: Article

References (59)

1. Anzil AP. Progressive supranuclear palsy, case report with pathological findings. Acta Neuropathol 1969;14:72-76
2. Arai N. "Grumose degeneration" of the dentate nucleus. A light and electron microscopic study in progressive supranuclear palsy and dentatorubropallidoluysial atrophy. J Neurol Sci 1989;90: 131-45
3. Takiyama Y, Oyanagi S, Kawashima S, et al. A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology 1994;44:1302-8
4. Kumada S, Hayashi M, Umitsu R, et al. Neuropathology of the dentate nucleus in developmental disorders. Acta Neuropathol 1997;94:36-41
5. Janota I. Pathological changes in the terminal parts of Purkinje cell axons in the dentate nucleus of the cerebellum. J Neurol Neurosurg Psychiatry 1973;36:596-603
6. Cruz-Sanchez FF, Rossi ML, Cardozo A, Picardo A, Tolosa E. Immunohistological study of grumose degeneration of the dentate nucleus in progressive supranuclear palsy. J Neurol Sci 1992;110: 228-31
7. Mizusawa H, Yen SH, Hirano A, Llena JF. Pathology of the dentate nucleus in progressive supranuclear palsy: A histological, immunohistochemical and ultrastructural study. Acta Neuropathol 1989;78:419-28
8. Voogd J, Feirabend HKP, Schoen JHR. Cerebellum and precerebellar nuclei. In: Paxinos G, eds. The human nervous system. San Diego: Academic Press, Inc., 1990:321-86
9. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19
10. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9
11. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm (Suppl) 1994;42:137-52
12. Steele JC, Richardson JC, Olszewski J, Progressive supranuclear palsy. Arch Neurol 1964;10:333-59
13. Behrman S, Carroll JD, Janota I, Matthews WB. Progressive supranuclear palsy, clinico-pathological study of four cases. Brain 1969;92:663-78
14. Suyama N, Kobayashi S, Isino H, Iijima M. Imaoka K. Progressive supranuclear palsy with palatal myoclonus. Acta Neuropathol 1997;94:290-93
15. Okumura A, Oda M, Iwase S, Shiraki H. Pathomorphological and clinicopathological study of so-called grumose degeneration in the cerebellar dentate nucleus. Adv Neurol Sci (Tokyo) 1977;19: 483-92
16. Shiraki H, Okumura A, Oyanagi S. Neuropathology of "grumose degeneration" of the cerebellar dentate nucleus with special reference to certain neurotoxic disorders and other pathological processes. In: Roizin L, Shiraki H, Crcevic N, eds. Neurotoxicology. New York: Raven Press, 1977:43-55
17. Irwin N, Madsen JR. Molecular biology of axonal outgrowth. Pediatr Neurosurg 1997;27:113-20
18. Aigner L, Arber S, Kapfhammer JP, et al. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 1995;83: 269-78
19. Benowitz LI, Routtenberg A. GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci 1997;20: 84-91
20. Honer WG, Kaufmann CA, Davies P. Characterization of a synaptic antigen of interest in neuropsychiatrie illness. Biol Psychiatry 1992;31:147-58
21. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer patients. Science 1986;232: 648-50
22. Ksiezak-Reding H, Dickson DW, Davies P, Yen SH. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA 1987;84: 3410-14
23. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38:1285-91
24. Honer WG, Hu L, Davies P. Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. Brain Res 1993;609:9-20
25. Greenberg SG, Davies P, Schein JD, Binder LI. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992;267:564-69
26. Kinney HC, Brody BA, Kloman AS, Gilles FH. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol 1988;47: 217-34
27. Sternberger NH, Sternberger LA, Ulrich J. Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci USA 1985;82:4274-76
28. Thomas PK, Scaravilli F, Belai A. Pathologic alterations in cell bodies of peripheral neurons in neuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy, 3rd edition. Philadelphia: Saunders, 1993:476-513
29. Barron KD, Doolin PF, Oldershaw JB. Ultrastructural observations on retrograde atrophy of lateral geniculate body. J Neuropathol Exp Neurol 1967;26:300-26
30. Feringa ER, Gilbertie WJ, Vahlsing HL. Histologic evidence for death of cortical neurons after spinal cord transection. Neurology 1984;34:1002-6
31. Ha H, Liu CN. Cell origin of the ventral spinocerebellar tract. J Comp Neurol 1968;133:185-206
32. Chung HD. Retrograde crossed cerebellar atrophy. Brain 1985;108: 881-95
33. Hanyu H, Arai H, Katsunuma H, Fujita R, Tomori C. [Crossed cerebellar atrophy following cerebrovascular lesions] (in Japanese with English abstract). Nippon Ronen lgakkai Zasshi 1991;28: 160-65
34. Matsumoto R, Nakano I, Arai N, Suda M, Oda M. Progressive supranuclear palsy with asymmetric lesions in the thalamus and cerebellum, with special reference to the unilateral predominance of many torpedoes. Acta Neuropathol 1996;92:640-44
35. Feasby TE, Hahn AF Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute-Guillain-Barré syndrome: Evidence of two different mechanisms? J Neurol Sci 1993;116: 185-92
36. Scolding N, Franklin R. Axon loss in multiple sclerosis. Lancet 1998;352:340-41
37. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85
38. Windebank AJ, Wood P, Bunge RP, Dyck PJ. Myelination determines the caliber of dorsal root ganglion neurons in culture. J Neurosci 1985;5:1563-69
39. Sanchez, I. Hassinger L, Paskevich PA, Shine HD, Nixon RA. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J Neurosci 1996;16:5095-5105
40. Yin X, Crawford TO, Griffin JW, et al. Myelin-associated glyco-protein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 1998;18:1953-62
41. Fruttiger M, Montag D, Schachner M, Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 1995;7:511-15
42. Chin SSM, Goldman JE. Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 1996;55:499-508
43. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100
44. Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J. Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 1998;153:735-44
45. Pakalnis A, Drake ME, Huber S, Paulson G, Phillips B. Central conduction time in progressive supranuclear palsy. Electromyogr clin Neurophysiol 1992;32:41-42
46. Abbruzzese G, Tabaton M, Morena M. Dall'Agata D, Favale E. Motor and sensory evoked potentials in progressive supranuclear palsy. Mov Disord 1991;6:49-54
47. Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 1994;174:157-59
48. Komori T, Shibata N, Kobayashi M, Sasaki S. Argyrophilic meshwork structures in the cerebral cortex of patients with progressive supranuclear palsy. Neuropathology 1996;16:1-5
49. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 1995;15:805-19
50. Kida E, Barcikowska M, Niemczewska M. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia. Acta Neuropathol 1992;83:328-32
51. Komori T, Shibata N, Kobayashi M, Sasaki S, Iwata M. Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy. Acta Neuropathol 1998;95:338-44
52. Dickson DW, Lee SC. Chapter 4, microglia. In: Davies RL, Robertson DM, eds. Textbook of neuropathology, third edition. Baltimore: Williams & Wilkins, 1997:165-205
53. Klegeris A, McGeer PL. Rat brain microglia and peritoneal macrophages show similar responses to respiratory burst stimulants. J Neuroimmunol 1994;53:83-90
54. Klegeris A, McGeer PL. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 1997;49:229-35
55. Giulian D, Haverkamp LJ, Yu JH, et al. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 1996;16:6021-37
56. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. GLIA 1993;7:75-83
57. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-46
58. Buffo A, Holtmaat AJ, Savio T, et al. Targeted overexpression of the neurite growth-associated protein B-50/GAP-43 in cerebellar Purkinje cells induces sprouting after axotomy but not axon regeneration into growth-permissive transplants. J Neurosci 1997;17: 8778-91
59. Dusart I, Sotelo C. Lack of Purkinje cell loss in adult rat cerebellum following protracted axotomy: Degenerative changes and regenerative attempts of the severed axons. J Comp Neurol 1994;347:211-32